Evidence map›Paper›PMID 27822411›Full record

ArticleAmerican journal of cancer research2016

Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts.

Doudou Li, Chao Qu, Zhouyu Ning, Haiyong Wang, Kun Zang, Liping Zhuang, Lianyu Chen, Peng Wang, Zhiqiang Meng

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Biology · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Versatile function of NF-ĸB in inflammation and cancer.Experimental hematology & oncology · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Doudou LiDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Chao QuDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Zhouyu NingDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Haiyong WangDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Kun ZangDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Liping ZhuangDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Lianyu ChenDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Peng WangDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Zhiqiang MengDepartment of Integrative Oncology, Fudan University Shanghai Cancer CenterShanghai, China; Department of Oncology, Shanghai Medical College, Fudan UniversityShanghai, China.
Fudan University Shanghai Cancer Center · CNIntegrative Medicine Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment is of crucial importance affecting treatment and prognosis. High degree of carcinoma-associated fibroblast (CAF) infiltration occurs in pancreatic cancer, though its effect on radiotherapy remains unclear. In this study, we demonstrated that radiation enhanced the migration- and invasion-promoting capacity of CAFs both in vitro and in vivo in a lung metastasis model. Radiation exposure increased the expression of CXCL12 by CAFs. CAF-derived CXCL12 promoted tumor cell EMT and invasion directly, acting through CXCR4 on pancreatic cancer cells. In addition, we showed that CXCL12-CXCR4 signaling promoted pancreatic cancer cell EMT and invasion by activating the P38 pathway. Therefore, our study concluded that radiation promoted pancreatic cancer cell invasion and EMT by activating CAFs, while inhibiting the CXCL12/CXCR4 interaction between pancreatic cancer cells and CAFs could potentially attenuate tumor cell invasion induced by radiation, which provides an opportunity for the development of novel therapeutic targets to improve the prognosis for human pancreatic cancer treated with radiation therapy.

Indexed as

carcinoma-associated fibroblastsepithelial-mesenchymal transitioninvasionpancreatic cancerRadiation

Identifiers

PMID27822411
PMCPMC5088285
OpenAlexW2562075475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.